TL;DR
Get backup power and energy gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Chemours confirmed that injunctions it issued against four exhibitors at Germany’s Chillventa trade fair concerned patents covering refrigerant blends containing R1234yf. The company identified five blends in its portfolio that include the refrigerant, but the report does not specify which products or alleged conduct were involved in the injunctions.
Chemours says the injunctions it issued against four exhibitors at Germany’s recent Chillventa trade fair concern patents for refrigerant blends containing R1234yf. The clarification identifies the technology at issue, but the available report does not name the exhibitors or describe the specific products and alleged infringements.
A Chemours spokesperson told the industry publication Cooling Post that the company’s injunctions concerned patents relating to R1234yf-containing blends. Chemours holds patents on blends that include the refrigerant, including R454B, R452A, R454A, R454C and R513A, the report said. It did not establish which of those blends, if any, were involved in each case.
The injunctions were issued during Chillventa, an exhibition for refrigeration, air conditioning and heat-pump industries. Chemours and another refrigerant manufacturer, Solstice, both announced injunction activity at the show. Solstice said it had issued five injunctions, but did not identify the refrigerants, describing its patents instead as covering the manufacturing process of a certain HFO and the composition of a proprietary HFO blend.
Chemours’ statement clarifies the subject of its own actions, not the legal findings or outcome. The report does not provide court names, case numbers, injunction wording, or responses from the affected exhibitors. The injunctions are legal measures; their issuance alone does not establish that a court has made a final ruling on infringement.
Patent Disputes Could Affect Refrigerant Supply
The dispute concerns intellectual property in refrigerant blends, products used across cooling and heating equipment markets. If injunctions restrict the sale, promotion or supply of particular products, manufacturers and distributors could face changes to their product plans or availability. The report, however, does not say what restrictions the orders impose or whether they have disrupted sales.
The clarification also helps distinguish the two companies’ actions. Chemours has tied its injunctions to R1234yf blends, while Solstice’s public description referred to patents involving an HFO manufacturing process and a proprietary blend. Those descriptions are not enough to conclude that the companies targeted the same products or legal issues. For customers and other suppliers, the practical effect remains uncertain until the affected products and terms of the orders are known.
As an affiliate, we earn on qualifying purchases.
Earlier HFO Patent Tensions
Chemours and Solstice have a history of joint development, patent cross-licensing and shared market protection related to newer hydrofluoroolefin refrigerants, according to the report. That background gives the injunction announcements added industry relevance, but it does not establish the scope or merits of the current cases.
In August, Chemours announced the launch of R1234ze(E) and the blend R515B under its Opteon brand. Solstice later said it was aware of another chemical company’s planned introduction of R1234ze and blends containing it. Solstice stated that it considered elements of its patent portfolio relevant to manufacturing processes for HFO-1234ze and said it had not licensed manufacturing-related intellectual property to others. That earlier exchange concerned R1234ze; Chemours’ clarification about the Chillventa injunctions instead points to blends containing R1234yf.
“The injunction patents related to 1234yf-containing blends.”
— Chemours spokesperson, speaking to Cooling Post
As an affiliate, we earn on qualifying purchases.
Exhibitors and Court Orders Not Identified
The available report does not name the four exhibitors targeted by Chemours, identify the specific products involved, or give details of the orders and proceedings. It is also unclear whether the injunctions are temporary or final, what conduct they restrict, and whether the affected parties have challenged them. No court ruling on the underlying patent allegations is described.
Likewise, Chemours’ list of five patented blends does not show that all five were part of the dispute. The report provides no confirmed information about sales, product withdrawals, supply effects or settlements. Solstice’s separate five injunctions should not be treated as part of Chemours’ cases.
As an affiliate, we earn on qualifying purchases.
Further Case Details Would Clarify Impact
The next useful developments would be publication or disclosure of the court orders, case records and affected products, along with responses from the exhibitors. Those details could show what conduct is restricted and whether the dispute changes product availability or market plans.
Until further information is reported, Chemours’ confirmation establishes the subject of its injunctions as patents concerning R1234yf-containing blends, but not the final legal status of the claims or their commercial consequences.
As an affiliate, we earn on qualifying purchases.
Key Questions
What do Chemours’ injunctions concern?
Chemours told Cooling Post that the patents behind its injunctions relate to refrigerant blends containing R1234yf.
Which blends did Chemours identify?
The report lists R454B, R452A, R454A, R454C and R513A as blends in Chemours’ patent portfolio that include R1234yf. It does not say which products were involved in the injunctions.
Who was targeted by the injunctions?
Chemours issued injunctions against four Chillventa exhibitors, but the available report does not name them.
Are Chemours’ and Solstice’s injunctions the same cases?
No such connection is established in the report. Chemours described its actions as relating to R1234yf blends; Solstice separately announced five injunctions and described patents involving an HFO manufacturing process and a proprietary blend.
Has a court found that the exhibitors infringed Chemours’ patents?
The report does not describe a final court finding. It reports that injunctions were issued and that Chemours says they concern its patents; the case outcomes and legal findings remain unclear.
Source: rss
Fall Picks
fall essentials
As an affiliate, we earn on qualifying purchases.
